Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

TolerRx gets $35mm with Series C private placement

Executive Summary

TolerRx (therapies for immunological tolerance) has raised $35mm with the completion of its Series C private placement. Lead investor Skyline Ventures was joined by existing investors Healthcare Ventures, Rho Ventures, and Vertex Management, plus new investors Sprout Group, Artal Services, Genentech, Lehman Brothers Healthcare Fund, Yasuda Enterprise Development, Mizuho Capital, Aozora Investment, and Duke University.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies